Clinical Trial Update: A Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine Alone or in Prime-Boost Regimens With Adjuvanted HIV-1 Envelope Trimer 4571 and HIV-1 Trimer 6931 Vaccines in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated safety, tolerability, and immunogenicity of an adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine given alone or in prime-boos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Adjuvanted HIV-1 Envelope Trimer 4571 Vaccine
• Adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine
• HIV-1 Trimer 6931 Vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 1 | Status: TERMINATED | Results posted: 2025-03-21